Exosens Shareholders Approve Key Resolutions at General Meeting

Exosens held its Combined General Meeting on 23 May 2025, chaired by Jean-Hubert Vial, with a quorum of over 77% approving all proposed resolutions. The company announced the approval of its 2024 financial statements by its shareholders. The meeting also marked the appointment of Bpifrance Investissement, represented by Dorianne Bonfils, as a director.

Shareholders agreed to a dividend of €0.10 per share, set to be paid on 30 May 2025. HLD Europe and Bpifrance Participations, key shareholders, played a significant role in the meeting as scrutineers. Exosens provides detailed information about the meeting, including presentations and voting results, on its website under the Investors section.